UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003197 |
|---|---|
| Receipt number | R000003846 |
| Scientific Title | A Phase III Study Comparing Methotrexate, Adrimycin and Cisplatin (MAP) with MAP + Ifosfamide (MAP + IF) for the Treatment of Osteosarcoma (JCOG0905/OS-MAP + IF-P3) |
| Date of disclosure of the study information | 2010/02/16 |
| Last modified on | 2021/01/06 13:41:38 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/02/16 15:39:37 | ||
| 2 | Update | 2010/08/16 15:59:50 | Name of person sending information Name of person sending information Institutions |
|
| 3 | Update | 2012/05/28 14:45:28 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
| 4 | Update | 2013/08/12 15:05:12 | Key exclusion criteria Key exclusion criteria |
|
| 5 | Update | 2013/08/12 15:16:41 | Last follow-up date |
|
| 6 | Update | 2014/06/27 14:11:57 | Last name of lead principal investigator Last name of lead principal investigator TEL TEL Institutions |
|
| 7 | Update | 2014/06/27 14:15:40 | Anticipated trial start date Last follow-up date |
|
| 8 | Update | 2016/05/02 13:32:07 | Key inclusion criteria Key inclusion criteria Target sample size |
|
| 9 | Update | 2016/05/02 13:35:04 | Name of primary person or sponsor Organization Organization Organization Category of Funding Organization Institutions |
|
| 10 | Update | 2016/05/02 13:35:49 | Last follow-up date |
|
| 11 | Update | 2021/01/06 13:41:38 | Recruitment status Date of IRB |
